367 related articles for article (PubMed ID: 4341954)
1. Drug-induced extrapyramidal disorders.
Chase TN
Res Publ Assoc Res Nerv Ment Dis; 1972; 50():448-71. PubMed ID: 4341954
[No Abstract] [Full Text] [Related]
2. [Study of extrapyramidal manifestations induced by neuroleptics].
Bordeleau JM; Tétreault L
Rev Can Biol; 1972; 31():Suppl:247-53. PubMed ID: 4403291
[No Abstract] [Full Text] [Related]
3. [Drug-induced extrapyramidal symptoms].
Janzik HH
Dtsch Med Wochenschr; 1975 Mar; 100(11):555-7. PubMed ID: 1116439
[No Abstract] [Full Text] [Related]
4. [Late irreversible extrapyramidal syndrome following neuroleptic use].
Boucebci M
Acta Psychiatr Belg; 1972 Mar; 72(2):233-40. PubMed ID: 5056017
[No Abstract] [Full Text] [Related]
5. Dopamine and extrapyramidal motor function and dysfunction.
Hornykiewicz O
Res Publ Assoc Res Nerv Ment Dis; 1972; 50():390-415. PubMed ID: 4561070
[No Abstract] [Full Text] [Related]
6. [Tranquilizing agents: extrapyramidal and antiparkinsonism activities].
Bordeleau JM; Tétreault L; Elie R
Vie Med Can Fr; 1972 Feb; 1(2):118-26. PubMed ID: 4637390
[No Abstract] [Full Text] [Related]
7. [Acute drug-induced extrapyramidal syndrome: case studies of a decade at the autonomous toxicology department of the Arcispedale].
Torrini M; Masini E; Ledda F; Mannaioni PF
Clin Ter; 1981 Jun; 97(6):561-85. PubMed ID: 7023804
[No Abstract] [Full Text] [Related]
8. Neuroleptics and the corpus striatum: clinical implications.
Stimmel GL
Dis Nerv Syst; 1976 Apr; 37(4):219-24. PubMed ID: 1253676
[No Abstract] [Full Text] [Related]
9. Phenothiazine toxicity in paediatric practice with three case reports.
Bajpai PC; Sethi VK; Pathak AK; Tripathi TK
Indian Pediatr; 1969 Jul; 6(7):470-5. PubMed ID: 5345025
[No Abstract] [Full Text] [Related]
10. [A chronic extrapyramidal syndrome as a complication of neuroleptic therapy].
Gurovich IIa; Fleĭs EP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(12):1862-8. PubMed ID: 5375563
[No Abstract] [Full Text] [Related]
11. [Complex persisting dyskinesia, secondary to neuroleptic therapy].
Castaigne P; Lapresle J; Chain F
Rev Neurol (Paris); 1969 Mar; 120(3):215-9. PubMed ID: 5343991
[No Abstract] [Full Text] [Related]
12. Dopamine, extrapyramidal system, and psychomotor function.
Papeschi R
Psychiatr Neurol Neurochir; 1972; 75(1):13-48. PubMed ID: 4625495
[No Abstract] [Full Text] [Related]
13. Structure side-effect sorting of drugs. I. Extrapyramidal syndrome.
Lien EJ; Gudauskas GA
J Pharm Sci; 1973 Apr; 62(4):645-7. PubMed ID: 4698989
[No Abstract] [Full Text] [Related]
14. [The drug-induced Parkinson's syndrome].
Pakesch E
Wien Z Nervenheilkd Grenzgeb; 1966; 23(1):140-6. PubMed ID: 4226879
[No Abstract] [Full Text] [Related]
15. Drug-induced movement disorders.
North RR
Postgrad Med; 1971 Sep; 50(3):180-5. PubMed ID: 5092993
[No Abstract] [Full Text] [Related]
16. [Extrapyramidal symptoms during the use of neuroleptics].
Ditfurth HV
Nervenarzt; 1967 Apr; 38(4):151-5. PubMed ID: 4382350
[No Abstract] [Full Text] [Related]
17. [The antipsychotic action of neuroleptics and basal ganglia function].
Arushanian EB
Farmakol Toksikol; 1973; 26(4):481-9. PubMed ID: 4151298
[No Abstract] [Full Text] [Related]
18. [Monoamines and choreic syndromes].
Constantinidis J
Rev Neurol (Paris); 1972 Jul; 127(1):65-77. PubMed ID: 4272133
[No Abstract] [Full Text] [Related]
19. Neutralization of extrapyramidal side-effects with Methixene.
Maller O; Heller S
Dis Nerv Syst; 1971 Jun; 32(6):409-15. PubMed ID: 5570695
[No Abstract] [Full Text] [Related]
20. [On the question of possible irreversible disorders due to psychopharmacotherapy].
Meyer HH
Arch Psychiatr Nervenkr (1970); 1966; 208(4):345-59. PubMed ID: 5969585
[No Abstract] [Full Text] [Related]
[Next] [New Search]
